Immuneering News

Immuneering | 10-Q: Q3 2024 Earnings Report

Nov 13 16:14 ET

Immuneering | 8-K: Immuneering Reports Third Quarter 2024 Financial Results and Provides Business Updates - Announced Positive Initial Data, Including Complete and Partial Responses, with IMM-1-104 in Combination with Chemotherapy in First-Line Pancreatic

Nov 13 16:08 ET

Immuneering | 8-K: Immuneering Reports Second Quarter 2024 Financial Results and Provides Business Updates - Enrollment progressing well across all arms in the IMM-1-104 Phase 2a Trial, with Initial Data from Multiple Arms Expected in 2H 2024 -

Aug 6 16:16 ET

Immuneering | 10-Q: Q2 2024 Earnings Report

Aug 6 16:14 ET

Immuneering | 8-K: Immuneering Reports First Quarter 2024 Financial Results and Provides Business Updates - Reported Positive Topline Results from Phase 1 Portion of its Phase 1/2a Clinical Trial of IMM-1-104 in RAS-Mutant Solid Tumors -

May 7 16:15 ET

Immuneering | 10-Q: Q1 2024 Earnings Report

May 7 16:11 ET

Immuneering | 10-K: FY2023 Annual Report

Mar 1 08:09 ET

Immuneering | 8-K: Immuneering Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Updates - Topline data from the Phase 1 portion of Phase 1/2a trial of IMM-1-104 expected in March 2024 -

Mar 1 08:06 ET

Immuneering | 10-Q: Q3 2023 Earnings Report

Nov 9, 2023 16:12 ET

Immuneering | 8-K: Immuneering Reports Third Quarter 2023 Financial Results and Provides Business Updates -Dose evaluation portion of IMM-1-104 Phase 1/2a trial approximately two-thirds enrolled; Immuneering's recommendation for a Phase 2 dose expected in

Nov 9, 2023 16:05 ET

Immuneering | 10-Q: Q2 2023 Earnings Report

Aug 3, 2023 16:10 ET

Immuneering | 10-Q: Q1 2023 Earnings Report

May 4, 2023 16:04 ET

Immuneering | 8-K: Immuneering Reports First Quarter 2023 Financial Results and Provides Business Updates

May 4, 2023 16:03 ET

Immuneering | 10-K: FY2022 Annual Report

Mar 6, 2023 16:06 ET

Immuneering | 8-K: Immuneering Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Updates

Mar 6, 2023 16:05 ET

Immuneering | 10-Q: Q3 2022 Earnings Report

Nov 10, 2022 09:05 ET

Immuneering | 8-K: Immuneering Reports Third Quarter 2022 Financial Results and Recent Business Highlights

Nov 10, 2022 09:00 ET

Immuneering | 10-Q: Q2 2022 Earnings Report

Aug 10, 2022 16:09 ET

Immuneering | 8-K: Immuneering Reports Second Quarter 2022 Financial Results and Recent Business Highlights

Aug 10, 2022 16:05 ET

Immuneering | 10-Q: Q1 2022 Earnings Report

May 10, 2022 06:36 ET